NEUVOGEN THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 24, 2024, a trademark application was filed for NEUVOGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NEUVOGEN THERAPEUTICS trademark a serial number of 98977356. The federal status of this trademark filing is REGISTERED as of Tuesday, January 27, 2026. This trademark is owned by Neuvogen, Inc.. The NEUVOGEN THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines
neuvogen therapeutics

General Information

Serial Number98977356
Word MarkNEUVOGEN THERAPEUTICS
Filing DateWednesday, April 24, 2024
Status700 - REGISTERED
Status DateTuesday, January 27, 2026
Registration Number8120880
Registration DateTuesday, January 27, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2024
Primary Code042
First Use Anywhere DateSaturday, November 30, 2024
First Use In Commerce DateSaturday, November 30, 2024

Trademark Owner History

Party NameNeuvogen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNeuvogen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNeuvogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Wednesday, April 24, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, September 5, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, October 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 7, 2024ASSIGNED TO EXAMINER
Friday, November 8, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2024EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 30, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 30, 2025SOU EXTENSION 1 FILED
Wednesday, July 30, 2025SOU EXTENSION 1 GRANTED
Thursday, July 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 18, 2025TEAS STATEMENT OF USE RECEIVED
Monday, August 18, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 18, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, December 31, 2025DIVISIONAL PROCESSING COMPLETE
Monday, August 18, 2025USE AMENDMENT FILED
Wednesday, December 31, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, January 2, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 2, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 27, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, January 27, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics neuvogen medicines vaccines development research